Please provide your email address to receive an email when new articles are posted on . Researchers identified elevated rates of congenital cytomegalovirus infection in lower income countries and ...
The preclinical data published in the American Journal of Transplantation will be presented in the form of a poster at the Cutting Edge of Transplantation (CEoT) Summit held in Scottsdale, Arizona, ...
From staying on top of your prenatal appointments to decorating the nursery, there’s so much to think about when you’re expecting a little one! Making sure that you stay healthy throughout your ...
Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...
Squadron plank owners reveal the new logo for Fleet Logistics Multi-Mission Squadron 30 “Titans” (VRM-30) at the establishment ceremony. Cmdr. Trevor F. Hermann, the commanding officer, VRM-30, looks ...
Sailors assigned to Fleet Logistics Multi-Mission Squadron (VRM) 30 direct a CMV-22B Osprey from the “Titans” of VRM 30 on the flight deck of Nimitz-class nuclear aircraft carrier USS Carl Vinson (CVN ...
CHICAGO (WLS) -- Many people have heard how dangerous the Zika virus can be to unborn babies. But there's another disease that can pose an even bigger risk to newborns. It's called the CMV virus, or ...
Please provide your email address to receive an email when new articles are posted on . University CMV testing among newborns is not common. In Minnesota, the first state with universal CMV testing, a ...
For first time, a new CMV-22B Osprey carried out landings and take-offs from the flight deck of an aircraft carrier. On Nov. 22, 2020, a CMV-22B tilt-rotor aircraft of the “Titans” of Fleet Logistics ...
Newborns with congenital cytomegalovirus (CMV) -- a common virus in the herpes family -- may have an increased risk of developing acute lymphocytic leukemia (ALL), according to new research published ...
Moderna is terminating the development of an mRNA vaccine in congenital cytomegalovirus (CMV) after it failed to show any significant benefit in a Phase III trial. Top line data from the CMVictory ...